aTyr Pharma, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +2,377.5% | -100.0% | – | -96.6% | -33.4% | -19.1% | |
| – | – | – | -20.8% | +4.6% | +1,783.1% | +23.1% | -92.5% | +30.0% | +61.7% | -43.8% | +0.8% | |
| – | – | – | – | – | – | – | – | – | -95.9% | -33.4% | -680.0% | |
| – | +105.7% | +28.2% | -32.0% | -32.2% | -31.1% | +23.1% | +34.5% | +84.0% | -1.2% | +28.6% | +10.8% | |
| – | +93.5% | – | – | – | – | -3.0% | +18.5% | +30.1% | -7.2% | +6.1% | +27.7% | |
| – | +102.2% | +22.7% | -20.5% | -30.9% | -70.8% | -3.0% | +260.5% | +68.4% | +0.3% | +23.3% | +11.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -16,000,100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.